BlackRock weighs in on AstraZeneca
Blackrock has publicly urged the AstraZeneca board to re-engage with potential buyer Pfizer
Blackrock has publicly urged the AstraZeneca board to re-engage with potential buyer Pfizer
|
|
Results of European elections under way today are very unlikely to cause major disruption in markets, fund managers have said
|
|
Periodic mini-crises have forced central banks to take aggressive action to shore up their currencies, often at the expense of the outlook for domestic growth, writes Threadneedle’s Mark Burgess.
|
|
The manager of the Global Equity Income fund plans to increase exposure by 3-4% in the next months.
|
|
Company planning to raise £12m through London Stock Exchange IPO
|
|
The fund launch comes in response to Europes changing fixed income environment.
|
|
David McFadzean of RBC Wealth Management favours the long game and looks at six funds that help balance a portfolio.
|
|
Rayner Spencer Mills Research is launching fund range and SRI rating services
|
|
No surprises are expected in tomorrow’s European Elections, but equities have room to move, says BlackRock’s Alice Gaskell.
|
|
The road back to normality is likely to be bumpy as the Fed reduces its asset purchases, according to the co-head of the multi asset team at Henderson Global Investors.
|
|
According to David Roberts, head of fixed income at Kames Capital, investors can be making small positive returns.
|
|
Kleinwort Benson appoints Simon Rees as head of fiduciary services arm
|
|